Large-cap Health Care company IQVIA has logged a -2.8% change today on a trading volume of 1,002,015. The average volume for the stock is 925,509.
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. Based in Durham, United States the company has 87,000 full time employees and a market cap of $38,993,997,824.
The company is now trading -15.4% away from its average analyst target price of $251.71 per share. The 21 analysts following the stock have set target prices ranging from $215.0 to $281.0, and on average give IQVIA a rating of buy.
Over the last 12 months IQV shares have declined by -5.0%, which represents a difference of -16.0% when compared to the S&P 500. The stock's 52 week high is $241.86 per share and its 52 week low is $165.75. With its net margins declining an average -8.6% over the last 6 years, IQVIA declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-15 | 14,410,000 | 1,091,000 | 8 | 14.29 |
| 2022-02-16 | 13,874,000 | 966,000 | 7 | 250.0 |
| 2021-02-12 | 11,359,000 | 279,000 | 2 | 0.0 |
| 2020-02-18 | 11,088,000 | 191,000 | 2 | 0.0 |
| 2019-02-19 | 10,412,000 | 259,000 | 2 | -84.62 |
| 2018-02-16 | 9,702,000 | 1,277,000 | 13 |
